CARBOPLATIN Side Effects

6959506-3 | Anaemia, Dehydration, Dysphagia, Malnutrition, Pneumonia
on Aug 26, 2010 Male patient from UNITED STATES , 70 years of age, weighting 136.7 lb, was diagnosed with non-small cell lung cancer and was treated with Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, dehydration, dysphagia, malnutrition, pneumonia (What is pneumonia?). Carboplatin dosage: Df=auc Recent Inf On 18feb10. During the same period patient was treated with PEMETREXED DISODIUM (Regimen 1:17-dec-2009 To Ongoing, 2 Regimen:11mar10 To 15apr10=36days) (View Pemetrexed Disodium Review and Pemetrexed Disodium Label ), BEVACIZUMAB (Regimen 1:17-dec-2009 To Ongoing, 2 Regimen:11mar10 To 15apr10=36days) (View Bevacizumab Review and Bevacizumab Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), CYANOCOBALAMIN ZINC TANNATE COMPLEX (View Cyanocobalamin-zinc Tannate Complex Review and Cyanocobalamin-zinc Tannate Complex Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), MEGACE (View Megace Review and Megace Label ). Patient was hospitalized.

6956968-2 | Blood Pressure Systolic Decreased, Dyspnoea, Febrile Neutropenia, Oxygen Saturation Decreased
Patient was taking Carboplatin (View Usage). Patient had the following side effects: blood pressure systolic decreased, dyspnoea, febrile neutropenia, oxygen saturation decreased on Aug 27, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 227.1 lb, . Carboplatin dosage: 1030 Mg. During the same period patient was treated with TAXOL (480 Mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6955521-4 | Neutropenia, White Blood Cell Count Decreased
Adverse event was reported on Aug 26, 2010 by a Female patient taking Carboplatin (View Usage) (Dosage: 650 Mg) . Location: KOREA, REPUBLIC OF , weighting 94.80 lb, After Carboplatin was administered, patient had the following side effects: neutropenia, white blood cell count decreased. During the same period patient was treated with TAXOL (248 Mg) (View Taxol Review and Taxol Label ).

6955515-9 | Neutrophil Count Decreased
on Aug 26, 2010 Female patient from UNITED STATES , weighting 147.7 lb, was treated with Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: neutrophil count decreased. Carboplatin dosage: 375 Mg. During the same period patient was treated with TAXOL (318.54 Mg) (View Taxol Review and Taxol Label ).


6955496-8 | Dysphagia, Febrile Neutropenia, Neutrophil Count Decreased, Oesophageal Pain, Oesophagitis, Pain Of Skin, Radiation Skin Injury, Skin Infection, Stomatitis
on Aug 24, 2010 Male patient from UNITED STATES , 64 years of age, weighting 156.5 lb, was diagnosed with non-small cell lung cancer and was treated with Carboplatin (View Usage). Patient had the following side effects: dysphagia, febrile neutropenia, neutrophil count decreased, oesophageal pain, oesophagitis, pain of skin, radiation skin injury, skin infection, stomatitis. Carboplatin dosage: Last Dose On 10aug2010(217mg) On Day 50 Last Dose Adm. During the same period patient was treated with ERBITUX (View Erbitux Review and Erbitux Label ), TAXOL (Last Dose On 10aug2010(85mg) On Day 50) (View Taxol Review and Taxol Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), MAGIC MOUTHWASH (View Magic Mouthwash Review and Magic Mouthwash Label ), SILVADENE (Cream) (View Silvadene Review and Silvadene Label ). Patient was hospitalized.

6944565-4 | Anaphylactic Reaction
Patient was taking Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: anaphylactic reaction on Aug 25, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 161.6 lb, . Carboplatin dosage: 497 Mg. During the same period patient was treated with TAXOTERE (137 Mg) (View Taxotere Review and Taxotere Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NIACIN (View Niacin Review and Niacin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6941467-4 | Haemoglobin Decreased, Neutrophil Count Decreased, Platelet Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Aug 24, 2010 by a Female patient taking Carboplatin (View Usage) (Dosage: 427 Mg) . Location: UNITED STATES , weighting 137.3 lb, Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, neutrophil count decreased, platelet count decreased, white blood cell count decreased. During the same period patient was treated with TAXOL (301 Mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6940337-5 | Activated Partial Thromboplastin Time Prolonged, Blood Bilirubin Increased, Blood Creatinine Increased, Confusional State, Hypernatraemia, Hyponatraemia, Oedema Peripheral, Rash Maculo-papular, Sepsis
on Aug 18, 2010 Male patient from UNITED STATES , 65 years of age, was diagnosed with acute myeloid leukaemia, escherichia bacteraemia, antifungal prophylaxis and was treated with Carboplatin (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged, blood bilirubin increased, blood creatinine increased, confusional state, hypernatraemia, hyponatraemia, oedema peripheral, rash maculo-papular, sepsis (What is sepsis?). Carboplatin dosage: 19-23mar2010,120mg/m2 Over 120hrs On Days 3-7,28d Cycle 23-25mar2010,dose Reduced By 30%. During the same period patient was treated with TOPOTECAN (6days,over 120hrs On Day 3-7 Of 28d Cycle) (View Topotecan Review and Topotecan Label ), PIPERACILLIN AND TAZOBACTAM (3days) (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), VANCOMYCIN (3days) (View Vancomycin Review and Vancomycin Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), LINEZOLID (View Linezolid Review and Linezolid Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), MICAFUNGIN SODIUM (View Micafungin Sodium Review and Micafungin Sodium Label ), AMBISOME (View Ambisome Review and Ambisome Label ).

6939635-0 | Arterial Occlusive Disease
on Aug 20, 2010 Male patient from KOREA, REPUBLIC OF , 71 years of age, was treated with Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: arterial occlusive disease. Carboplatin dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ).

6938099-0 | Abdominal Pain, Diarrhoea, Hypotension, Neutropenic Colitis, Pyrexia, Tachycardia, Vomiting
Patient was taking Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), diarrhoea, hypotension, neutropenic colitis, pyrexia, tachycardia, vomiting on Aug 04, 2010 from DENMARK Additional patient health information: Female patient , 46 years of age, . Carboplatin dosage: (day 1-3). During the same period patient was treated with ETOPOSIDE ((120 Mg/m2, Day 1-3)) (View Etoposide Review and Etoposide Label ). Patient was hospitalized.

6937783-2 | Activated Partial Thromboplastin Time Prolonged, Blood Bilirubin Increased, Blood Creatinine Increased, Confusional State, Hypernatraemia, Hyponatraemia, Oedema Peripheral, Rash Maculo-papular, Sepsis
Adverse event was reported on Aug 18, 2010 by a Male patient taking Carboplatin (View Usage) (Dosage: 19-23mar2010,120mg/m2 Over 120hrs On Days 3-7,28d Cycle 23-25mar2010,dose Reduced By 30%) was diagnosed with acute myeloid leukaemia, escherichia bacteraemia, antifungal prophylaxis and. Location: UNITED STATES , 65 years of age, Patient had the following side effects: activated partial thromboplastin time prolonged, blood bilirubin increased, blood creatinine increased, confusional state, hypernatraemia, hyponatraemia, oedema peripheral, rash maculo-papular, sepsis (What is sepsis?). During the same period patient was treated with TOPOTECAN (6days,over 120hrs On Day 3-7 Of 28d Cycle) (View Topotecan Review and Topotecan Label ), PIPERACILLIN AND TAZOBACTAM (3days) (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), VANCOMYCIN (3days) (View Vancomycin Review and Vancomycin Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), LINEZOLID (View Linezolid Review and Linezolid Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), MICAFUNGIN SODIUM (View Micafungin Sodium Review and Micafungin Sodium Label ), AMBISOME (View Ambisome Review and Ambisome Label ).

6936900-8 | Dyspnoea At Rest
on Aug 18, 2010 Male patient from UNITED STATES , 67 years of age, weighting 172.0 lb, was diagnosed with metastases to bone, metastases to central nervous system and was treated with Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: dyspnoea at rest. Carboplatin dosage: . During the same period patient was treated with PEMETREXED DISODIUM (View Pemetrexed Disodium Review and Pemetrexed Disodium Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ).

6935988-8 | Sepsis, Shock
on Aug 18, 2010 Male patient from UNITED STATES , 64 years of age, was diagnosed with non-small cell lung cancer, cough and was treated with Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: sepsis (What is sepsis?), shock. Carboplatin dosage: Last Dose On 29jul10(412mg). During the same period patient was treated with ABRAXANE (Last Dose On 29jul10(570mg)) (View Abraxane Review and Abraxane Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENZONATATE (View Benzonatate Review and Benzonatate Label ), CALCIUM CITRATE (View Calcium Citrate Review and Calcium Citrate Label ), CELEBREX (View Celebrex Review and Celebrex Label ), CENTRUM (View Centrum Review and Centrum Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6935842-1 | Burning Sensation, Chills, Cough, Dehydration, Dyspnoea, Fatigue, Hypophagia, Leukopenia, Malaise
Patient was taking Carboplatin (View Usage). Patient had the following side effects: burning sensation, chills, cough, dehydration, dyspnoea, fatigue, hypophagia, leukopenia, malaise on Aug 19, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 239.4 lb, . Carboplatin dosage: 198 Mg. During the same period patient was treated with TAXOL (102 Mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6934980-7 | Headache, Oedema Peripheral, Vomiting
Adverse event was reported on Aug 18, 2010 by a Female patient taking Carboplatin (View Usage) (Dosage: Day 1 For Each Cycle Every 21d 594mg, 445mg On 3f10,10mr,31mr,21ap,12my2010.) was diagnosed with neoplasm, headache (What is headache?), constipation (What is constipation?), depression (What is depression?), anxiety (What is anxiety?) and. Location: UNITED STATES , 33 years of age, weighting 200.6 lb, After Carboplatin was administered, patient had the following side effects: headache (What is headache?), oedema peripheral, vomiting. During the same period patient was treated with GEMCITABINE (Day One And Day 8 Of Each Cycle (1000mg/m2 Total Dose 2030mg)03feb2010, 2030mg On 10feb2010) (View Gemcitabine Review and Gemcitabine Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), RIZATRIPTAN BENZOATE (View Rizatriptan Benzoate Review and Rizatriptan Benzoate Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), LORAZEPAM (1 In 6hrs Prn) (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6934585-8 | Asthenia, Loss Of Consciousness, Nausea, Pyrexia, Septic Shock
on Aug 16, 2010 Male patient from UNITED STATES , weighting 200.0 lb, was diagnosed with lung neoplasm malignant and was treated with Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, loss of consciousness, nausea (What is nausea?), pyrexia, septic shock. Carboplatin dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ).

6933581-4 | Acute Pulmonary Oedema, Renal Failure
on Aug 18, 2010 Male patient from UNITED STATES , 76 years of age, was diagnosed with non-small cell lung cancer, hypertension, depression (What is depression?), urinary tract infection (What is urinary tract infection?), nausea (What is nausea?), myalgia and was treated with Carboplatin (View Usage). Patient had the following side effects: acute pulmonary oedema, renal failure. Carboplatin dosage: . During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), FLUOXETINE HCL (View Fluoxetine Hcl Review and Fluoxetine Hcl Label ), CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6933040-9 | Pneumothorax, Procedural Complication
Patient was taking Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: pneumothorax, procedural complication on Aug 18, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 62.17 lb, was diagnosed with dyspnoea and. Carboplatin dosage: 110 Mg. During the same period patient was treated with TAXOL (48 Mg) (View Taxol Review and Taxol Label ).

6933026-4 | Neutropenia
Adverse event was reported on Aug 18, 2010 by a Male patient taking Carboplatin (View Usage) (Dosage: 441 Mg Other Iv) was diagnosed with hepatic neoplasm malignant and. Location: UNITED STATES , 66 years of age, weighting 240.3 lb, Patient experienced the following unwanted or unexpected effects: neutropenia. Patient was hospitalized.

6930985-0 | Febrile Neutropenia, Flank Pain
on Aug 17, 2010 Female patient from UNITED STATES , weighting 177.5 lb, was treated with Carboplatin (View Usage). Patient had the following side effects: febrile neutropenia, flank pain. Carboplatin dosage: Carboplatin 720mg Days 1 Iv. During the same period patient was treated with ETOPOSIDE (Etoposide 191mg Days 1, 2, And 3 Iv) (View Etoposide Review and Etoposide Label ), COMPAZINE (View Compazine Review and Compazine Label ), ATIVAN (View Ativan Review and Ativan Label ), PERCOCET (View Percocet Review and Percocet Label ), DARVOCET N 100 (View Darvocet-n 100 Review and Darvocet-n 100 Label ), ALLEGRA (View Allegra Review and Allegra Label ). Patient was hospitalized.

6930825-X | Mucosal Inflammation, Oral Pain, Weight Decreased
on Aug 16, 2010 Male patient from UNITED STATES , 58 years of age, was diagnosed with head and neck cancer (What is head and neck cancer?) and was treated with Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: mucosal inflammation, oral pain, weight decreased. Carboplatin dosage: Last Dose On :22mar2010. During the same period patient was treated with CISPLATIN (Last Dose On:07feb2010) (View Cisplatin Review and Cisplatin Label ), ABRAXANE (Last Dose On:07feb2010) (View Abraxane Review and Abraxane Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), FENTANYL 75 (View Fentanyl-75 Review and Fentanyl-75 Label ), MORPHINE (1df=5mg/ml) (View Morphine Review and Morphine Label ), ENSURE (1df= 7 Cans (via G Tube)) (View Ensure Review and Ensure Label ), NORMAL SALINE (View Normal Saline Review and Normal Saline Label ). Patient was hospitalized.

6929713-4 | Hypercapnia, Hypoxia, Malignant Neoplasm Progression, Non-small Cell Lung Cancer, Tuberculosis
Patient was taking Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: hypercapnia, hypoxia, malignant neoplasm progression, non-small cell lung cancer, tuberculosis (What is tuberculosis?) on Aug 03, 2010 from TURKEY Additional patient health information: Female patient , 29 years of age, was diagnosed with non-small cell lung cancer and. Carboplatin dosage: . During the same period patient was treated with GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ). Patient was hospitalized.

6929292-1 | Colitis, Vomiting
Adverse event was reported on Aug 16, 2010 by a Female patient taking Carboplatin (View Usage) (Dosage: Auc 5,interrupted On 28jul10 Dai 1of 8,restarted On 3aug10 Day 1of 15.) was diagnosed with ovarian cancer, hypothyroidism, hyperlipidaemia, hypertension, anxiety (What is anxiety?), abdominal pain (What is abdominal pain?), pelvic pain (What is pelvic pain?) and. Location: UNITED KINGDOM , 69 years of age, weighting 163.1 lb, Patient had the following side effects: colitis, vomiting. During the same period patient was treated with PACLITAXEL (Interrupted On 28jul10 Dai 1of 8,restarted On 3aug10 Day 1of 15) (View Paclitaxel Review and Paclitaxel Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), AZOR (View Azor Review and Azor Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), LORTAB (1df=10/500mg) (View Lortab Review and Lortab Label ). Patient was hospitalized.

6928882-X | Deep Vein Thrombosis, Dyspnoea, Renal Failure Acute
on Aug 12, 2010 Female patient from UNITED STATES , 57 years of age, weighting 147.7 lb, was diagnosed with non-small cell lung cancer stage iv, hypertension, gastrooesophageal reflux disease, lung neoplasm malignant, pain (What is pain?), hyperlipidaemia and was treated with Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), dyspnoea, renal failure acute. Carboplatin dosage: Recent Dose:03jun10 Discontinued On 24jun10 6df:6auc. During the same period patient was treated with ALIMTA (Recent Dose:03jun10 Discontinued On 24jun10) (View Alimta Review and Alimta Label ), BEVACIZUMAB (Recent Dose:03jun10 Discontinued On 24jun10) (View Bevacizumab Review and Bevacizumab Label ), PROCARDIA (View Procardia Review and Procardia Label ), PROTONIX (View Protonix Review and Protonix Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ). Patient was hospitalized.

6928824-7 | Sepsis, Shock
on Aug 13, 2010 Male patient from UNITED STATES , 64 years of age, was diagnosed with non-small cell lung cancer, cough and was treated with Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: sepsis (What is sepsis?), shock. Carboplatin dosage: Last Dose On 29jul10(412mg). During the same period patient was treated with ABRAXANE (Last Dose On 29jul10(570mg)) (View Abraxane Review and Abraxane Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENZONATATE (View Benzonatate Review and Benzonatate Label ), CALCIUM CITRATE (View Calcium Citrate Review and Calcium Citrate Label ), CELEBREX (View Celebrex Review and Celebrex Label ), CENTRUM (View Centrum Review and Centrum Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6928001-X | Cerebral Ischaemia
Patient was taking Carboplatin (View Usage). Patient had the following side effects: cerebral ischaemia on Aug 11, 2010 from AUSTRALIA Additional patient health information: Male patient , 46 years of age, was diagnosed with glioblastoma multiforme and. Carboplatin dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), AVASTIN (10mg/kg On Day 2 Of Every 3 Week Cycle.) (View Avastin Review and Avastin Label ).

6927400-X | Type I Hypersensitivity
Adverse event was reported on Aug 09, 2010 by a Female patient taking Carboplatin (View Usage) (Dosage: ) was diagnosed with glioma and. Location: THAILAND , child 12 years of age, After Carboplatin was administered, patient had the following side effects: type i hypersensitivity.

6927207-3 | Hepatitis C
on Aug 13, 2010 Male patient from UNITED STATES , 46 years of age, weighting 127.9 lb, was diagnosed with non-small cell lung cancer and was treated with Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis c (What is hepatitis c?). Carboplatin dosage: . During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), HYDROMORPHONE (View Hydromorphone Review and Hydromorphone Label ), VICODIN (View Vicodin Review and Vicodin Label ).

6925862-5 | Haemoglobin Decreased, Neutrophil Count Decreased
on Aug 13, 2010 Female patient from UNITED STATES , weighting 236.5 lb, was treated with Carboplatin (View Usage). Patient had the following side effects: haemoglobin decreased, neutrophil count decreased. Carboplatin dosage: 5171 Mg. During the same period patient was treated with TAXOTERE (1013 Mg) (View Taxotere Review and Taxotere Label ), HERCEPTIN (3823 Mg) (View Herceptin Review and Herceptin Label ), NEULASTA (View Neulasta Review and Neulasta Label ).

6925861-3 | Neutrophil Count Decreased
Patient was taking Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: neutrophil count decreased on Aug 13, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 116.8 lb, . Carboplatin dosage: 483.6 Mg. During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ). Patient was hospitalized.

6925816-9 | Neutrophil Count Decreased
Adverse event was reported on Aug 13, 2010 by a Female patient taking Carboplatin (View Usage) (Dosage: 483.6 Mg) . Location: UNITED STATES , weighting 119.0 lb, Patient experienced the following unwanted or unexpected effects: neutrophil count decreased. During the same period patient was treated with TAXOL (267.78 Mg) (View Taxol Review and Taxol Label ).

6925617-1 | Neutrophil Count Decreased
on Aug 13, 2010 Female patient from UNITED STATES , weighting 116.8 lb, was treated with Carboplatin (View Usage). Patient had the following side effects: neutrophil count decreased. Carboplatin dosage: 483.6 Mg. During the same period patient was treated with TAXOL (267.78 Mg) (View Taxol Review and Taxol Label ).

6925388-9 | Chest Discomfort, Dyspnoea, Flushing, Infusion Related Reaction
on Aug 13, 2010 Female patient from UNITED STATES , 70 years of age, weighting 163.0 lb, was diagnosed with non-small cell lung cancer and was treated with Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: chest discomfort, dyspnoea, flushing, infusion related reaction. Carboplatin dosage: 315 Mg.

6921928-4 | Acute Myeloid Leukaemia, Sepsis
Patient was taking Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, sepsis (What is sepsis?) on Jul 29, 2010 from JAPAN Additional patient health information: Male patient , 69 years of age, was diagnosed with lung adenocarcinoma stage iv and. Carboplatin dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ).

6921860-6 | Dehydration, Hypotension
Adverse event was reported on Aug 09, 2010 by a Male patient taking Carboplatin (View Usage) (Dosage: Recent Dose On 15jul10 (585 Mg).) was diagnosed with non-small cell lung cancer and. Location: UNITED STATES , 52 years of age, Patient had the following side effects: dehydration, hypotension. During the same period patient was treated with ABRAXANE (Recent Dose On 15jul10 (504 Mg);interrupted On 05aug2010.) (View Abraxane Review and Abraxane Label ), OXYCODONE HCL (Every 4 Hours As Needed.) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), AMITRIPTYLINE HYDROCHLORIDE (Every Night At Bedtime.) (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), THIAMINE HCL (View Thiamine Hcl Review and Thiamine Hcl Label ). Patient was hospitalized.

6919740-5 | Febrile Neutropenia, Pancytopenia
on Aug 10, 2010 Male patient from UNITED STATES , 63 years of age, weighting 176.4 lb, was treated with Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: febrile neutropenia, pancytopenia. Carboplatin dosage: 676mg Daily X3 Iv. During the same period patient was treated with ETOPOSIDE (204mg Daily X3 Iv) (View Etoposide Review and Etoposide Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), GLYBURIDE AND METFORMIN HYDROCHLORIDE (View Glyburide And Metformin Hydrochloride Review and Glyburide And Metformin Hydrochloride Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), BIAFINE (View Biafine Review and Biafine Label ), SENNA S (View Senna-s Review and Senna-s Label ), NYSTATIN RINSE (View Nystatin Rinse Review and Nystatin Rinse Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ). Patient was hospitalized.

6919511-X | Deep Vein Thrombosis, Embolism Arterial, Erythema, Pulmonary Embolism, Skin Warm
on Aug 10, 2010 Female patient from UNITED STATES , weighting 247.5 lb, was treated with Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), embolism arterial, erythema, pulmonary embolism (What is pulmonary embolism?), skin warm. Carboplatin dosage: 565 Mg. During the same period patient was treated with TAXOL (350 Mg) (View Taxol Review and Taxol Label ), NEULASTA (6 Mg) (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6917253-8 | Cough
Patient was taking Carboplatin (View Usage). Patient had the following side effects: cough on Jul 27, 2010 from DENMARK Additional patient health information: Female patient , 71 years of age, weighting 119.0 lb, was diagnosed with ovarian cancer and. Carboplatin dosage: 472 Mg Milligram(s), Intravenous. During the same period patient was treated with PACLITAXEL (283 Mg Milligram(s), Intravenous) (View Paclitaxel Review and Paclitaxel Label ), (PARACETAMOL) (View (paracetamol) Review and (paracetamol) Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), (CALCIUM) (View (calcium) Review and (calcium) Label ). Patient was hospitalized.

6914694-X | Platelet Count Decreased
Adverse event was reported on Aug 04, 2010 by a Female patient taking Carboplatin (View Usage) (Dosage: 2373 Mg) . Location: UNITED STATES , weighting 110.9 lb, After Carboplatin was administered, patient had the following side effects: platelet count decreased. During the same period patient was treated with CYCLOPHOSPHAMIDE (918 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HYDROCHLORIDE (92 Mg) (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), TAXOL (1342 Mg) (View Taxol Review and Taxol Label ), BACTRIM (View Bactrim Review and Bactrim Label ), DECADRON (View Decadron Review and Decadron Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), FAMVIR (View Famvir Review and Famvir Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6914329-6 | Colitis, Vomiting
on Aug 05, 2010 Female patient from UNITED KINGDOM , 69 years of age, weighting 163.1 lb, was diagnosed with ovarian cancer, hypothyroidism, hyperlipidaemia, hypertension, anxiety (What is anxiety?), abdominal pain (What is abdominal pain?), pelvic pain (What is pelvic pain?) and was treated with Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: colitis, vomiting. Carboplatin dosage: Auc 5. During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), AZOR (View Azor Review and Azor Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), LORTAB (1df=10/500mg) (View Lortab Review and Lortab Label ). Patient was hospitalized.

6914315-6 | Hepatitis C
on Aug 04, 2010 Male patient from UNITED STATES , 46 years of age, weighting 127.9 lb, was diagnosed with non-small cell lung cancer and was treated with Carboplatin (View Usage). Patient had the following side effects: hepatitis c (What is hepatitis c?). Carboplatin dosage: . During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), METHADONE (View Methadone Review and Methadone Label ), HYDROMORPHONE (View Hydromorphone Review and Hydromorphone Label ), VICODIN (View Vicodin Review and Vicodin Label ).

6913190-3 | Arthritis, Back Pain, Blood Pressure Increased, Feeling Abnormal, Feeling Cold, Haemorrhoids, Hypoacusis, Malignant Neoplasm Progression, Menopausal Symptoms
Patient was taking Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: arthritis (What is arthritis?), back pain (What is back pain?), blood pressure increased, feeling abnormal, feeling cold, haemorrhoids, hypoacusis, malignant neoplasm progression, menopausal symptoms on Jul 29, 2010 from UNITED STATES Additional patient health information: Female patient , 59 years of age, was diagnosed with endometrial cancer, pain (What is pain?), lung neoplasm malignant, anxiety (What is anxiety?) and. Carboplatin dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), MEGACE (View Megace Review and Megace Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), TAMOXIFEN (View Tamoxifen Review and Tamoxifen Label ), MEGESTROL (View Megestrol Review and Megestrol Label ), XANAX (View Xanax Review and Xanax Label ), BENADRYL (Also Topical) (View Benadryl Review and Benadryl Label ), MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.

6909041-3 | Deep Vein Thrombosis
Adverse event was reported on Aug 02, 2010 by a Female patient taking Carboplatin (View Usage) (Dosage: Interrupted On 12apr10;6df:6auc Discont On 19apr10) was diagnosed with non-small cell lung cancer, pain (What is pain?), cough and. Location: UNITED STATES , 66 years of age, weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?). During the same period patient was treated with ALIMTA (17sp09-29mr10(194d)(last Dose-29mr10) Intp 13apr10,194d Discon 19ap10 Last Dose(ind Phase)18nv09) (View Alimta Review and Alimta Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), IBUPROFEN (ADVIL) (View Ibuprofen (advil) Review and Ibuprofen (advil) Label ), TUSSIONEX (View Tussionex Review and Tussionex Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6907362-1 | Anaemia, Arterial Occlusive Disease, Peripheral Ischaemia, Raynaud's Phenomenon
on Jul 22, 2010 Male patient from FRANCE , 73 years of age, was diagnosed with transitional cell carcinoma and was treated with Carboplatin (View Usage). Patient had the following side effects: anaemia, arterial occlusive disease, peripheral ischaemia, raynaud's phenomenon. Carboplatin dosage: 300 Mg Milligram(s). During the same period patient was treated with GEMCITABINE HCL (1850 Mg Milligram(s)) (View Gemcitabine Hcl Review and Gemcitabine Hcl Label ).

6906230-9 | Neutrophil Count Decreased
on Aug 03, 2010 Female patient from UNITED STATES , weighting 116.8 lb, was treated with Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: neutrophil count decreased. Carboplatin dosage: 483.6 Mg. During the same period patient was treated with TAXOL (267.78 Mg) (View Taxol Review and Taxol Label ).

6905915-8 | Atrial Fibrillation, Atrial Flutter, Supraventricular Tachycardia, Syncope
Patient was taking Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), atrial flutter, supraventricular tachycardia, syncope on Aug 03, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 152.1 lb, . Carboplatin dosage: 578 Mg. During the same period patient was treated with TAXOL (356 Mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6905901-8 | Deep Vein Thrombosis, Erythema, Feeling Hot, Oedema, Oedema Peripheral, Pain In Extremity, Pulmonary Embolism
Adverse event was reported on Aug 03, 2010 by a Female patient taking Carboplatin (View Usage) (Dosage: 565 Mg) . Location: UNITED STATES , weighting 247.5 lb, Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), erythema, feeling hot, oedema, oedema peripheral, pain in extremity, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with TAXOL (350 Mg) (View Taxol Review and Taxol Label ), NEULASTA (6 Mg) (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6905899-2 | Pulmonary Embolism
on Aug 03, 2010 Female patient from UNITED STATES , weighting 216.1 lb, was treated with Carboplatin (View Usage). After Carboplatin was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Carboplatin dosage: 560 Mg. During the same period patient was treated with ETOPOSIDE (627 Mg) (View Etoposide Review and Etoposide Label ). Patient was hospitalized.

6902001-8 | Deep Vein Thrombosis, Pulmonary Embolism
on Aug 02, 2010 Female patient from UNITED STATES , weighting 247.5 lb, was treated with Carboplatin (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?). Carboplatin dosage: 565 Mg. During the same period patient was treated with TAXOL (350 Mg) (View Taxol Review and Taxol Label ), NEULASTA (6 Mg) (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6899968-3 | Renal Tubular Necrosis
Patient was taking Carboplatin (View Usage). Patient had the following side effects: renal tubular necrosis on Jul 28, 2010 from UNITED STATES Additional patient health information: Male patient , 75 years of age, weighting 163.1 lb, was diagnosed with non-small cell lung cancer and. Carboplatin dosage: . During the same period patient was treated with PEMETREXED DISODIUM (View Pemetrexed Disodium Review and Pemetrexed Disodium Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), WHOLE BLOOD (View Whole Blood Review and Whole Blood Label ), NEULASTA (Ongoing.) (View Neulasta Review and Neulasta Label ), FOLIC ACID (Ongoing.) (View Folic Acid Review and Folic Acid Label ), DEXAMETHASONE (Ongoing.) (View Dexamethasone Review and Dexamethasone Label ), PREDNISONE (Ongoing.) (View Prednisone Review and Prednisone Label ), BENADRYL (Ongoing.) (View Benadryl Review and Benadryl Label ). Patient was hospitalized.